Rufinamide for refractory focal seizures: An open-label, multicenter European study

Seizure

Volumn 22, Issue 1, 2013, Pages 33-36

  Coppola, Giangennaro ^a   Zamponi, Nelia ^b   Kluger, Gerhard ^c   Mueller, Arndt ^c   Anna Rita, Mazzotta ^d   Parisi, Pasquale ^d   Isone, Claudia ^a   Santoro, Elena ^a   Curatolo, Paolo ^e   Verrotti, Alberto ^f  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Schon Klinik Vogtareuth   (Germany)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adjunctive; Cryptogenic; Refractory focal seizures; Rufinamide; Symptomatic

Indexed keywords

ANTICONVULSIVE AGENT; RUFINAMIDE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGED; AGITATION; ANOREXIA; ANXIETY DISORDER; ARTICLE; ATAXIA; BODY WEIGHT; CAREGIVER; CHILD; CHILDHOOD DISEASE; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EUROPE; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; FRONTAL LOBE EPILEPSY; GERMANY; HEADACHE; HUMAN; INFORMED CONSENT; IRRITABILITY; ITALY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFRACTORY FOCAL SEIZURE; SCHOOL CHILD; SIDE EFFECT; TONIC CLONIC SEIZURE; VOMITING;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEIZURES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 84872138605     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2012.09.015     Document Type: Article

References (18)

1. H.S. White, M.R. Franklin, H.J. Kupferberg, M. Schmutz, J.P. Stables, and H.H. Wolf The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models Epilepsia 49 2008 1213 1220
2. T. Glauser, G. Kluger, R. Sachdeo, G. Krauss, C. Perdomo, and S. Arroyo Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome Neurology 70 2008 1950 1958
3. G. Coppola, S. Grosso, Franzoni, P. Veggiotti, N. Zamponi, and P. Parisi Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience Seizure 19 2010 587 591
4. G. Kluger, T. Glauser, G. Krauss, R. Seeruthun, C. Perdomo, and S. Arroyo Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study Acta Neurologica Scandinavica 122 2010 202 208
5. G. Coppola, S. Grosso, E. Franzoni, P. Veggiotti, N. Zamponi, and P. Parisi Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome European Journal of Neurology 18 2011 246 251
6. C. Von Stüpnagel, G. Coppola, P. Striano, A. Müller, M. Staudt, and G. Kluger First long-term experience with the orphan drug rufinamide in children with myoclonic-Astatic epilepsy (Doose syndrome) European Journal of Paediatric Neurology 2012 [Epub ahead of print]
7. A. Mueller, R. Boor, G. Coppola, P. Striano, M. Dahlin, and C. von Stuelpnagel Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome Epilepsy & Behavior 21 2011 282 284
8. M. Vendrame, A. Poduri, T. Loddenkemper, G. Kluger, G. Coppola, and S.V. Kothare Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases Epileptic Disorders 13 2011 18 21
9. S. Palhagen, R. Canger, O. Henriksen, J.A. van Parys, M.E. Riviére, and M.A. Karolchyk Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy Epilepsy Research 43 2001 115 124
10. C.E. Elger, H. Stefan, A. Mann, M. Narurkar, Y. Sun, and C. Perdomo A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures Epilepsy Research 88 2010 255 263
11. M.J. Brodie, W.E. Rosenfeld, B. Vazquez, R. Sachdeo, C. Perdomo, and A. Mann Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial Epilepsia 50 2009 1899 1909
12. V. Biton, G. Krauss, B. Vasquez-Santana, F. Bibbiani, A. Mann, and C. Perdomo A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures Epilepsia 52 2011 234 242
13. G. Kluger, G. Kurlemann, E. Haberlandt, J.P. Ernst, U. Runge, and F. Schneider Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience Epilepsy & Behavior 14 2009 491 495
14. G. Kluger, E. Haberlandt, G. Kurlemann, J.P. Ernst, U. Runge, and F. Schneider First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy Epilepsy & Behavior 17 2010 546 548
15. M. Vendrame, T. Loddenkemper, V.D. Gooty, M. Takeoka, A. Rotenberg, and A.M. Bergin Experience with rufinamide in a pediatric population: a single center's experience Pediatric Neurology 43 2010 155 158
16. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures Epilepsia 22 1981 489 501
17. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes Epilepsia 30 1989 389 399
18. E. Perucca, J. Cloyd, D. Critchley, and E. Fuseau Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy Epilepsia 49 2008 1123 1141